A Bias-Corrected Net Reclassification Improvement for Clinical Subgroups

被引:31
作者
Paynter, Nina P. [1 ]
Cook, Nancy R. [1 ]
机构
[1] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA
关键词
cardiology; internal medicine; preventive medicine-screening; public health; STATISTICS-IN-MEDICINE; PENCINA; M.J; ET-AL; HEART-DISEASE RISK; PREDICTIVE ABILITY; ROC CURVE; ATHEROSCLEROSIS RISK; MODELS; MARKER; AREA; COMMUNITIES;
D O I
10.1177/0272989X12461856
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background. Comparing prediction models using reclassification within subgroups at intermediate risk is often of clinical interest. Objective. To demonstrate a method for obtaining an unbiased estimate for the Net Reclassification Improvement (NRI) evaluated only on a subset, the clinical NRI. Study Design and Setting. We derived the expected value of the clinical NRI under the null hypothesis using the same principles as the overall NRI. We then conducted a simulation study based on a logistic model with a known predictor and a potential predictor, varying the effects of the known and potential predictors to test the performance of our bias-corrected clinical NRI measure. Finally, data from the Women's Health Study, a prospective cohort of 24 171 female health professionals, were used as an example of the proposed method. Results. Our bias-corrected estimate is shown to have a mean of zero in the null case under a range of simulated parameters and, unlike the naive estimate, to be unbiased. We also provide 2 methods for obtaining a variance estimate, both with reasonable type 1 errors. Conclusion. Our proposed method is an improvement over currently used methods of calculating the clinical NRI and is recommended to reduce overly optimistic results.
引用
收藏
页码:154 / 162
页数:9
相关论文
共 24 条
[1]   Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Reclassification of Coronary Heart Disease Risk and Implications for Lipid-Modifying Therapy in the Atherosclerosis Risk in Communities Study [J].
Brautbar, Ariel ;
Ballantyne, Christie M. ;
Lawson, Kim ;
Nambi, Vijay ;
Chambless, Lloyd ;
Folsom, Aaron R. ;
Willerson, James T. ;
Boerwinkle, Eric .
CIRCULATION-CARDIOVASCULAR GENETICS, 2009, 2 (03) :279-U175
[2]   Several methods to assess improvement in risk prediction models: Extension to survival analysis [J].
Chambless, Lloyd E. ;
Cummiskey, Christopher P. ;
Cui, Gang .
STATISTICS IN MEDICINE, 2011, 30 (01) :22-38
[3]  
Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987
[4]   Use and misuse of the receiver operating characteristic curve in risk prediction [J].
Cook, Nancy R. .
CIRCULATION, 2007, 115 (07) :928-935
[5]   Performance of reclassification statistics in comparing risk prediction models [J].
Cook, Nancy R. ;
Paynter, Nina P. .
BIOMETRICAL JOURNAL, 2011, 53 (02) :237-258
[6]   The need for reorientation toward cost-effective prediction:: Comments on 'Evaluating the added predictive ability of a new marker:: From area under the ROC curve to reclassification and beyond' by M. J.!Pencina et al., Statistics in Medicine [J].
Greenland, Sander .
STATISTICS IN MEDICINE, 2008, 27 (02) :199-206
[7]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[8]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[9]  
2-4
[10]  
Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278